Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions
Recruiting · NCT07737171 · Observational (researchers observe without assigning treatment) · Lead sponsor: The University of Texas Health Science Center, Houston
View the official record on ClinicalTrials.gov →Interventions studied
Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA)
What this trial is about
This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Diagnosis of any pancreatic pre-malignant lesion and/or pancreatic malignancy
- Patients already undergoing EUS-RFA for treatment of pancreatic lesions clinically
Exclusion criteria
- Patients with co-existing malignancies of other organs (or a prior history of such)
- Patients unable to provide informed consent
- Patients unable to complete follow-up
Where it is running
1 location listed across 1 US state.
- The University of Texas Health Science Center at Houston - Houston, Texas, United States